US Stocks Gain; PepsiCo Posts Upbeat Earnings
Portfolio Pulse from Lisa Levin
US stocks traded higher with the Dow Jones gaining more than 50 points. PepsiCo Inc reported better-than-expected earnings for its third quarter, with sales growth of 6.7% year-on-year to $23.45 billion. SMX, SuperCom Ltd, and CISO Global Inc shares rose significantly, while Akero Therapeutics, Athersys, Inc, and 89bio, Inc shares dropped. Oil traded down 0.4% while gold traded up 0.2%.
October 10, 2023 | 1:40 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CISO Global Inc shares were up, gaining 56% after its Argo Edge Cloud Security Platform was independently valued at $49 million.
The independent valuation of CISO Global's Argo Edge Cloud Security Platform has led to a significant increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
PepsiCo reported better-than-expected Q3 earnings, with sales growth of 6.7% YoY to $23.45 billion.
PepsiCo's better-than-expected earnings report is likely to boost investor confidence and could lead to a short-term increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
SMX shares shot up 92% after the company announced it secured a majority take in True Gold Consortium.
The announcement of SMX securing a majority stake in True Gold Consortium has led to a significant increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Shares of SuperCom Ltd got a boost, shooting 82% up.
SuperCom Ltd's shares have seen a significant increase, which could be due to a variety of factors such as positive news or market trends.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Akero Therapeutics shares dropped 61% after the company reported a 36-week analysis of its Phase 2b SYMMETRY study.
The release of the 36-week analysis of Akero Therapeutics' Phase 2b SYMMETRY study has led to a significant decrease in the company's stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Shares of Athersys, Inc were down 61% after the company reported interim analysis results of MASTERS-2 clinical study.
The release of the interim analysis results of Athersys, Inc's MASTERS-2 clinical study has led to a significant decrease in the company's stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
89bio, Inc was down, falling 31%.
89bio, Inc's shares have seen a significant decrease, which could be due to a variety of factors such as negative news or market trends.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100